- Home
- MIO vs SOPH Comparison
MIO vs SOPH Comparison
Compare MIO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIO
- SOPH
- Stock Information
- Founded
- MIO 2021
- SOPH 2011
- Country
- MIO United States
- SOPH Switzerland
- Employees
- MIO N/A
- SOPH N/A
- Industry
- MIO Investment Managers
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MIO Finance
- SOPH Health Care
- Exchange
- MIO Nasdaq
- SOPH Nasdaq
- Market Cap
- MIO 209.0M
- SOPH 247.0M
- IPO Year
- MIO N/A
- SOPH 2021
- Fundamental
- Price
- MIO $12.05
- SOPH $3.20
- Analyst Decision
- MIO
- SOPH Strong Buy
- Analyst Count
- MIO 0
- SOPH 3
- Target Price
- MIO N/A
- SOPH $7.00
- AVG Volume (30 Days)
- MIO 46.0K
- SOPH 31.0K
- Earning Date
- MIO 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- MIO 4.57%
- SOPH N/A
- EPS Growth
- MIO N/A
- SOPH N/A
- EPS
- MIO N/A
- SOPH N/A
- Revenue
- MIO N/A
- SOPH $64,488,000.00
- Revenue This Year
- MIO N/A
- SOPH $7.34
- Revenue Next Year
- MIO N/A
- SOPH $20.25
- P/E Ratio
- MIO N/A
- SOPH N/A
- Revenue Growth
- MIO N/A
- SOPH 9.85
- 52 Week Low
- MIO $9.18
- SOPH $2.70
- 52 Week High
- MIO $11.36
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- MIO 43.67
- SOPH 41.43
- Support Level
- MIO $12.08
- SOPH $3.13
- Resistance Level
- MIO $12.24
- SOPH $3.99
- Average True Range (ATR)
- MIO 0.10
- SOPH 0.24
- MACD
- MIO 0.00
- SOPH -0.05
- Stochastic Oscillator
- MIO 51.14
- SOPH 8.14
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.